@#Pulmonary
adenocarcinoma in situ is reclassified as precursor glandular lesions in the fifth edition of
WHO classification of thoracic tumours, causing widespread
attention and heated debate among domestic thoracic
oncologists,
radiologists,
pathologists and
surgeons. We would like to
comment on the topic and make a few
suggestions on the management of pulmonary nodule during
lung cancer screening. We are open to all
suggestion and welcome debates.